12-55987006-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002868.4(RAB5B):āc.46A>Gā(p.Ser16Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,551,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002868.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB5B | NM_002868.4 | c.46A>G | p.Ser16Gly | missense_variant | 2/6 | ENST00000360299.10 | NP_002859.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB5B | ENST00000360299.10 | c.46A>G | p.Ser16Gly | missense_variant | 2/6 | 1 | NM_002868.4 | ENSP00000353444.5 |
Frequencies
GnomAD3 genomes AF: 0.00000690 AC: 1AN: 144852Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251456Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135910
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1406762Hom.: 0 Cov.: 34 AF XY: 0.00000715 AC XY: 5AN XY: 699162
GnomAD4 genome AF: 0.00000690 AC: 1AN: 144852Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 70172
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2022 | The c.46A>G (p.S16G) alteration is located in exon 2 (coding exon 1) of the RAB5B gene. This alteration results from a A to G substitution at nucleotide position 46, causing the serine (S) at amino acid position 16 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at